Antibody that specifically binds hyaluronan synthase
Modulation of Hyaluronan (HA) synthesis and degradation is disclosed by compounds and compositions that are capable of reducing the level of hyaluronan synthase (HAS) or hyaluronidase (HYAL) or the function or activity of HAS or HYAL. The compounds and compositions can also inhibit the expression of genetic material encoding these enzymes. The compounds and compositions comprise nucleic acid molecules and interactive molecules such as antibodies, small molecule inhibitors and substrate analogs of HAS and HYAL. The compounds and compositions are useful in the prophylaxis and/or treatment of inflammatory disorders including hyperproliferative conditions, such as but not limited to, cancer and psoriasis.
1. An isolated antibody which reduces the level of hyaluronan synthase (HAS) activity wherein said antibody specifically binds targeted antigen of SEQ ID NO:26 within HAS 1.
2. The isolated antibody of claim 1 , wherein the antibody is selected from a monoclonal antibody, polyclonal antibody, and antigen-binding fragment and a humanized antibody.
3. The isolated antibody of claim 2 , wherein the antibody is a monoclonal antibody or an antigen-binding fragment thereof.
4. The isolated antibody of claim 1 , wherein the HAS activity is selected from the group consisting of HAS1, HAS2 and HAS3 activity.
5. The isolated antibody of claim 4 , wherein the antibody is selected from a monoclonal antibody, polyclonal antibody, and antigen-binding fragment and a humanized antibody.
6. The isolated antibody of claim 5 , wherein the antibody is a monoclonal antibody or an antigen-binding fragment thereof.
7. A pharmaceutical composition comprising an antibody of claim 1 and one or more pharmaceutically acceptable carriers and/or diluents.